---
schema_version: "secwatch.filing_event.v1"
accession: "0001178913-26-002988"
form_type: "8-K"
ticker: "SLXN"
cik: "0002022416"
company_name: "Silexion Therapeutics Corp"
filed_at: "2026-05-29T11:00:25+00:00"
generated_at: "2026-05-29T11:05:40.234955+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Silexion Therapeutics completes 1-for-10 reverse share split; warrants adjusted

## Summary
- 1-for-10 reverse share split effective after close May 28; shares trade on split-adjusted basis May 29 under ticker SLXN.
- Authorized shares reduced to 5.9M; par value increased to $0.135 per share.
- Each warrant now exercisable for 1/10 share at $15,525.00 per whole share (was $1,552.50).
- Shareholders approved reverse split at reconvened EGM on May 5, 2026.
- Split intended to maintain compliance with Nasdaq minimum bid price requirement.

## SEC filing metadata
- accession: 0001178913-26-002988
- form_type: 8-K
- ticker: SLXN
- cik: 0002022416
- company_name: Silexion Therapeutics Corp
- filed_at: 2026-05-29T11:00:25+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.03, 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2022416/000117891326002988/0001178913-26-002988-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2022416/000117891326002988/zk2635442.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001178913-26-002988
- JSON: https://secwatch.observer/filing/0001178913-26-002988.json
- Plain text: https://secwatch.observer/filing/0001178913-26-002988.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.